Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
In terms of region, the global ophthalmic anti-infective market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global ophthalmic anti-infective market due to availability of advanced drug formulations in the region. Awareness among people about diseases is also a major factor boosting the market in the region. The ophthalmic anti-infective market in Asia Pacific is anticipated to expand at a rapid pace due to increase in incidence of eye infection in the region. Lack of awareness about diseases and unavailability of advanced medication and formulations in underdeveloped countries, such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the growth of the ophthalmic anti-infective market in Middle East & Africa.
The global Anti-infective Ophthalmic market is valued at 1410 million US$ in 2018 and will reach 1520 million US$ by the end of 2025, growing at a CAGR of 1.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-infective Ophthalmic market based on company, product type, end user and key regions.
This report studies the global market size of Anti-infective Ophthalmic in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-infective Ophthalmic in these regions.
This research report categorizes the global Anti-infective Ophthalmic market by top players/brands, region, type and end user. This report also studies the global Anti-infective Ophthalmic market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Allergan
Valeant Pharmaceuticals
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Market size by Product
Antibacterial
Antiviral
Antifungal
Anti-parasitic
Others
Market size by End User
Hospital Use
Clinic Use
Household
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Anti-infective Ophthalmic market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Anti-infective Ophthalmic market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-infective Ophthalmic companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Anti-infective Ophthalmic submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Anti-infective Ophthalmic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-infective Ophthalmic market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Anti-infective Ophthalmic Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-infective Ophthalmic Market Size Growth Rate by Product
1.4.2 Antibacterial
1.4.3 Antiviral
1.4.4 Antifungal
1.4.5 Anti-parasitic
1.4.6 Others
1.5 Market by End User
1.5.1 Global Anti-infective Ophthalmic Market Size Growth Rate by End User
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Household
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-infective Ophthalmic Market Size
2.1.1 Global Anti-infective Ophthalmic Revenue 2014-2025
2.1.2 Global Anti-infective Ophthalmic Sales 2014-2025
2.2 Anti-infective Ophthalmic Growth Rate by Regions
2.2.1 Global Anti-infective Ophthalmic Sales by Regions
2.2.2 Global Anti-infective Ophthalmic Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anti-infective Ophthalmic Sales by Manufacturers
3.1.1 Anti-infective Ophthalmic Sales by Manufacturers
3.1.2 Anti-infective Ophthalmic Sales Market Share by Manufacturers
3.1.3 Global Anti-infective Ophthalmic Market Concentration Ratio (CR5 and HHI)
3.2 Anti-infective Ophthalmic Revenue by Manufacturers
3.2.1 Anti-infective Ophthalmic Revenue by Manufacturers (2014-2019)
3.2.2 Anti-infective Ophthalmic Revenue Share by Manufacturers (2014-2019)
3.3 Anti-infective Ophthalmic Price by Manufacturers
3.4 Anti-infective Ophthalmic Manufacturing Base Distribution, Product Types
3.4.1 Anti-infective Ophthalmic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-infective Ophthalmic Product Type
3.4.3 Date of International Manufacturers Enter into Anti-infective Ophthalmic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Anti-infective Ophthalmic Sales by Product
4.2 Global Anti-infective Ophthalmic Revenue by Product
4.3 Anti-infective Ophthalmic Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Anti-infective Ophthalmic Breakdown Data by End User
6 North America
6.1 North America Anti-infective Ophthalmic by Countries
6.1.1 North America Anti-infective Ophthalmic Sales by Countries
6.1.2 North America Anti-infective Ophthalmic Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-infective Ophthalmic by Product
6.3 North America Anti-infective Ophthalmic by End User
7 Europe
7.1 Europe Anti-infective Ophthalmic by Countries
7.1.1 Europe Anti-infective Ophthalmic Sales by Countries
7.1.2 Europe Anti-infective Ophthalmic Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-infective Ophthalmic by Product
7.3 Europe Anti-infective Ophthalmic by End User
8 Asia Pacific
8.1 Asia Pacific Anti-infective Ophthalmic by Countries
8.1.1 Asia Pacific Anti-infective Ophthalmic Sales by Countries
8.1.2 Asia Pacific Anti-infective Ophthalmic Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-infective Ophthalmic by Product
8.3 Asia Pacific Anti-infective Ophthalmic by End User
9 Central & South America
9.1 Central & South America Anti-infective Ophthalmic by Countries
9.1.1 Central & South America Anti-infective Ophthalmic Sales by Countries
9.1.2 Central & South America Anti-infective Ophthalmic Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-infective Ophthalmic by Product
9.3 Central & South America Anti-infective Ophthalmic by End User
10 Middle East and Africa
10.1 Middle East and Africa Anti-infective Ophthalmic by Countries
10.1.1 Middle East and Africa Anti-infective Ophthalmic Sales by Countries
10.1.2 Middle East and Africa Anti-infective Ophthalmic Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-infective Ophthalmic by Product
10.3 Middle East and Africa Anti-infective Ophthalmic by End User
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Anti-infective Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis Anti-infective Ophthalmic Products Offered
11.1.5 Novartis Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Business Overview
11.2.3 Allergan Anti-infective Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Allergan Anti-infective Ophthalmic Products Offered
11.2.5 Allergan Recent Development
11.3 Valeant Pharmaceuticals
11.3.1 Valeant Pharmaceuticals Company Details
11.3.2 Company Business Overview
11.3.3 Valeant Pharmaceuticals Anti-infective Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Valeant Pharmaceuticals Anti-infective Ophthalmic Products Offered
11.3.5 Valeant Pharmaceuticals Recent Development
11.4 Santen Pharmaceutical
11.4.1 Santen Pharmaceutical Company Details
11.4.2 Company Business Overview
11.4.3 Santen Pharmaceutical Anti-infective Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Santen Pharmaceutical Anti-infective Ophthalmic Products Offered
11.4.5 Santen Pharmaceutical Recent Development
11.5 Lupin Pharmaceuticals
11.5.1 Lupin Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Lupin Pharmaceuticals Anti-infective Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Lupin Pharmaceuticals Anti-infective Ophthalmic Products Offered
11.5.5 Lupin Pharmaceuticals Recent Development
11.6 Apotex
11.6.1 Apotex Company Details
11.6.2 Company Business Overview
11.6.3 Apotex Anti-infective Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Apotex Anti-infective Ophthalmic Products Offered
11.6.5 Apotex Recent Development
11.7 Akorn
11.7.1 Akorn Company Details
11.7.2 Company Business Overview
11.7.3 Akorn Anti-infective Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Akorn Anti-infective Ophthalmic Products Offered
11.7.5 Akorn Recent Development
12 Future Forecast
12.1 Anti-infective Ophthalmic Market Forecast by Regions
12.1.1 Global Anti-infective Ophthalmic Sales Forecast by Regions 2019-2025
12.1.2 Global Anti-infective Ophthalmic Revenue Forecast by Regions 2019-2025
12.2 Anti-infective Ophthalmic Market Forecast by Product
12.2.1 Global Anti-infective Ophthalmic Sales Forecast by Product 2019-2025
12.2.2 Global Anti-infective Ophthalmic Revenue Forecast by Product 2019-2025
12.3 Anti-infective Ophthalmic Market Forecast by End User
12.4 North America Anti-infective Ophthalmic Forecast
12.5 Europe Anti-infective Ophthalmic Forecast
12.6 Asia Pacific Anti-infective Ophthalmic Forecast
12.7 Central & South America Anti-infective Ophthalmic Forecast
12.8 Middle East and Africa Anti-infective Ophthalmic Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-infective Ophthalmic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer